查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604589

抗焦虑药物市场：按类型、剂型、给药途径、适应症、分销管道 - 全球预测 2025-2030

Anxiolytics Market by Type (Antidepressants, Antihistamines, Azapirones), Form (Capsules, Tablets), Route of Administration, Indication, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗焦虑药物市值为12.4亿美元，预计2024年将达到13.2亿美元，复合年增长率为7.27%，到2030年将达到20.3亿美元。

抗焦虑药物市场主要包括为缓解焦虑症状而开发的药物和干预措施，其决定性因素是心理健康意识的提高、焦虑症盛行率的增加以及持续的药物进步。随着焦虑症影响数百万人，并且需要各种药物解决方案，包括苯二氮平类药物、SSRIs、SNRIs、非典型抗精神病药物和自然疗法等新型治疗方法，对抗焦虑药物的需求不断增长，日益严重的全球心理健康危机凸显了这一点。其用途范围从治疗整体焦虑症到辅助性忧郁症管理和创伤后压力症候群 (PTSD)，其多功能性对于个人化患者照护至关重要。最终用途范围涵盖精神科、医院和门诊病人护理机构，并反映出与急性和慢性治疗方法的显着整合。市场成长受到医疗保健支出增加、给药系统技术进步以及远距远端医疗服务快速扩张等因素的显着影响。此外，新兴市场对精神健康保健的认识和接受度不断提高，带来了广阔的市场扩张机会。然而，成长面临着严格的法律规范、高昂的治疗成本以及与某些抗焦虑药物（如苯二氮平类药物）相关的滥用和依赖的可能性的挑战。创新的关键领域包括开发非成瘾性抗焦虑药物、利用基因组学的个人化医疗方法以及旨在补充药物干预的数位疗法。神经调节和基于大麻素的解决方案的前沿研究也提供了市场发展潜力。儘管竞争格局充满挑战，但製药公司和研究机构之间的持续伙伴关係提供了克服监管障碍和优化药物疗效的途径。市场的本质是具有弹性和适应性的，受到科学进步、不断变化的社会观念以及对有效心理健康解决方案的持久需求的推动。这些见解凸显了以创新为目标、解决现有挑战以维持成长的积极主动的方法。

主要市场统计
基准年[2023] 12.4亿美元
预测年份 [2024] 13.2亿美元
预测年份 [2030] 20.3亿美元
复合年增长率（%） 7.27%

市场动态：揭示快速发展的抗焦虑药物市场的关键市场洞察

抗焦虑药物市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 焦虑症盛行率不断上升，人们对心理健康和治疗的认识不断提高
    • 抗焦虑药物作为麻醉镇静剂的出现
  • 市场限制因素
    • 长期服用抗焦虑药物带来的副作用问题
  • 市场机会
    • 医药领域抗焦虑药物的技术进展
    • 政府措施
  • 市场挑战
    • 与精神障碍相关的社会耻辱相关问题

波特的五力：驾驭焦虑药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解抗焦虑药物市场的外部影响

外部宏观环境因素在塑造抗焦虑药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解抗焦虑药物市场竞争状况

抗焦虑药物市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵抗焦虑药物市场供应商的绩效评估

FPNV定位矩阵是评估抗焦虑药物市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了抗焦虑药物市场的成功之路

焦虑药物市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 焦虑症盛行率不断上升，人们对心理健康和治疗的认识不断提高
      • 抗焦虑药物作为麻醉镇静剂的出现
    • 抑制因素
      • 与长期使用抗焦虑药物的副作用相关的问题
    • 机会
      • 医药领域抗焦虑药物的技术进展
      • 加强政府促进心理健康和福祉的努力
    • 任务
      • 与精神障碍相关的社会耻辱议题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章抗焦虑药物市场：依类型

  • 抗忧郁症
  • 抗组织胺药
  • 阿札匹隆
  • 苯二氮平类
  • β受体阻断剂
  • 非苯二氮平类药物
  • 镇静催眠

第七章抗焦虑药物市场：依形式

  • 胶囊
  • 药片

第八章焦虑药物市场：依给药途径

  • 口服
  • 胃肠外的

第九章 抗焦虑药物适应症市场

  • 整体焦虑症
  • 恐慌症
  • 恐惧症
  • 创伤后压力症候群（PTSD）

第10章抗焦虑药市场：依通路划分

  • 离线
  • 在线的

第十一章美洲抗焦虑药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区焦虑药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲抗焦虑药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Accord Healthcare US
  • Akorn Operating Company LLC
  • Alvogen
  • Amneal Pharmaceuticals LLC
  • Apotex Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Dellwich Healthcare LLP
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Hameln Pharma GmbH
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Lifecare Neuro Products Limited
  • Lifegenix
  • Neurocon Inc.
  • Noreva Biotech
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
Product Code: MRR-C002B1C9948A

The Anxiolytics Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.32 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 2.03 billion by 2030.

The anxiolytics market, which encompasses medications and interventions primarily developed to alleviate anxiety symptoms, operates in a dynamic field critically shaped by rising mental health awareness, increasing prevalence of anxiety disorders, and ongoing pharmaceutical advancements. The necessity for anxiolytics is underscored by the mounting global mental health crisis, with anxiety disorders impacting millions and necessitating a diverse range of pharmacological solutions that include benzodiazepines, SSRIs, SNRIs, and novel therapeutics like atypical antipsychotics and natural remedies. Their applications are extensive, ranging from generalized anxiety disorder treatment to adjuncts in depression management and PTSD, making their versatility essential for personalized patient care. The end-use scope spans across psychiatric facilities, hospitals, and outpatient care settings, reflecting their critical integration into both acute and chronic treatment regimens. Market growth is significantly influenced by factors such as increasing healthcare expenditure, technological advancements in drug delivery systems, and the rapid expansion of telehealth services, which enhance accessibility. Additionally, burgeoning awareness and acceptance of mental health care in developing regions present promising market expansion opportunities. However, growth is challenged by stringent regulatory frameworks, high costs of treatment, and potential abuse and dependency associated with certain anxiolytics like benzodiazepines. Key areas for innovation include the development of non-addictive anxiolytics, personalized medicine approaches leveraging genomics, and digital therapeutics aimed at complementing pharmaceutical interventions. Cutting-edge research into neuromodulation and cannabinoid-based solutions also offers potential avenues for market evolution. While the market landscape is competitive, ongoing partnerships between pharmaceutical companies and research institutions offer pathways to navigate regulatory hurdles and optimize drug efficacy. The nature of the market is both resilient and adaptive, driven by scientific progression, shifting societal perceptions, and an enduring demand for effective mental health solutions. These insights underscore a proactive approach in targeting innovations and addressing existing challenges to sustain growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.32 billion
Forecast Year [2030] USD 2.03 billion
CAGR (%) 7.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anxiolytics Market

The Anxiolytics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
    • Emergence of anxiolytics as sedative agents in anesthesia
  • Market Restraints
    • Problems associated with side effects after prolonged use of anxiolytics
  • Market Opportunities
    • Technical advancement of anxiolytic drugs in pharmaceutical sector
    • Increasing government initiatives to promote mental health and wellbeing
  • Market Challenges
    • Problems related to social-stigma associated with mental disorders

Porter's Five Forces: A Strategic Tool for Navigating the Anxiolytics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anxiolytics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anxiolytics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anxiolytics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anxiolytics Market

A detailed market share analysis in the Anxiolytics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anxiolytics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anxiolytics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anxiolytics Market

A strategic analysis of the Anxiolytics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anxiolytics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare US, Akorn Operating Company LLC, Alvogen, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Dellwich Healthcare LLP, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Hameln Pharma GmbH, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lifecare Neuro Products Limited, Lifegenix, Neurocon Inc., Noreva Biotech, Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Anxiolytics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Antidepressants, Antihistamines, Azapirones, Benzodiazepines, Beta-blockers, Nonbenzodiazepines, and Sedative-hypnotics.
  • Based on Form, market is studied across Capsules and Tablets.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on Indication, market is studied across Generalized Anxiety Disorder, Panic Disorder, Phobias, and Posttraumatic Stress Disorder (PTSD).
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
      • 5.1.1.2. Emergence of anxiolytics as sedative agents in anesthesia
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with side effects after prolonged use of anxiolytics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancement of anxiolytic drugs in pharmaceutical sector
      • 5.1.3.2. Increasing government initiatives to promote mental health and wellbeing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems related to social-stigma associated with mental disorders
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anxiolytics Market, by Type

  • 6.1. Introduction
  • 6.2. Antidepressants
  • 6.3. Antihistamines
  • 6.4. Azapirones
  • 6.5. Benzodiazepines
  • 6.6. Beta-blockers
  • 6.7. Nonbenzodiazepines
  • 6.8. Sedative-hypnotics

7. Anxiolytics Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Tablets

8. Anxiolytics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral

9. Anxiolytics Market, by Indication

  • 9.1. Introduction
  • 9.2. Generalized Anxiety Disorder
  • 9.3. Panic Disorder
  • 9.4. Phobias
  • 9.5. Posttraumatic Stress Disorder (PTSD)

10. Anxiolytics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Anxiolytics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Anxiolytics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Anxiolytics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Accord Healthcare US
  • 3. Akorn Operating Company LLC
  • 4. Alvogen
  • 5. Amneal Pharmaceuticals LLC
  • 6. Apotex Inc.
  • 7. AstraZeneca PLC
  • 8. Bausch Health Companies Inc.
  • 9. Dellwich Healthcare LLP
  • 10. Eli Lilly and Company
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. GlaxoSmithKline PLC
  • 13. H. Lundbeck A/S
  • 14. Hameln Pharma GmbH
  • 15. Hikma Pharmaceuticals PLC
  • 16. Johnson & Johnson Services, Inc.
  • 17. Lifecare Neuro Products Limited
  • 18. Lifegenix
  • 19. Neurocon Inc.
  • 20. Noreva Biotech
  • 21. Novartis AG
  • 22. Pfizer Inc.
  • 23. Sanofi S.A.
  • 24. Sun Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ANXIOLYTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANXIOLYTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANXIOLYTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANXIOLYTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANXIOLYTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANXIOLYTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANXIOLYTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANXIOLYTICS MARKET SIZE, BY AZAPIRONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANXIOLYTICS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANXIOLYTICS MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANXIOLYTICS MARKET SIZE, BY NONBENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANXIOLYTICS MARKET SIZE, BY SEDATIVE-HYPNOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANXIOLYTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANXIOLYTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANXIOLYTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANXIOLYTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANXIOLYTICS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANXIOLYTICS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANXIOLYTICS MARKET SIZE, BY PHOBIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANXIOLYTICS MARKET SIZE, BY POSTTRAUMATIC STRESS DISORDER (PTSD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANXIOLYTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANXIOLYTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023